
We only serve healthcare companies, but that's a big world. In order to provide the highest level of expertise, we focus on certain healthcare sectors where we are most experienced.
Life Sciences Investment Banking
|
| Therapeutics |
Pharmaceutical Outsourcing |
| Specialty Pharmaceuticals |
Contract Research Organizations |
| Biotechnology (therapeutic products) |
Pharmaceutical Information Technology |
| |
Sales & Marketing Services |
|
|
Healthcare Products and
Services Investment Banking |
| Medical Technology |
Services |
Medical Devices
|
Distribution |
| Analytical Instruments & Reagents |
Healthcare Information Technology |
Capital Equipment
|
Specialty Labs |
|
|

Our experience includes representing many private venture-backed and self-financed companies, as well as emerging and middle market public companies. In these assignments, we observed that such companies could often benefit from additional business development support to pursue new opportunities or to build shareholder value by selling or out-licensing intellectual property. In addition, given current capital markets conditions, many companies today are compelled to fully evaluate a comprehensive range of partnering alternatives as a means to raise capital and minimize dilution from selling equity at an unfavorable time, if it equity investors can be found at all.
To address this need, Edgemont provides a broad range of strategic business development support services, including identifying partners and structuring agreements for approved and pre-approval products such as product development collaborations, marketing, co-marketing and licensing agreements, as well as buy and sell-side representation for product rights
and service lines.

Our clients include public and privately-held companies. We focus on companies with entrepreneurial and dynamic management teams. Edgemont's principals' entrepreneurial backgrounds and extensive experience banking entrepreneurs provides us with a keen appreciation and insight into the unique needs of such businesses.